Paul Bisaro, Director at Myriad Genetics, holds 157.14K shares in Myriad Genetics (Ticker: MYGN), holds 27.86K shares in Zoetis (Ticker: ZTS), holds 32.05K shares in Mallinckrodt public limited company (Ticker: MNKTQ).
Paul Bisaro latest transaction was an Uninformative Buy of ―.
What was Paul Bisaro's most profitable transaction?
Paul Bisaro’s most profitable transaction was an Informative Buy of ZTS stock on May 13, 2026. The return on the trade was 4.70%.
What is Paul Bisaro's role in Myriad Genetics?
Paul Bisaro's role in Myriad Genetics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.